Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,754 public trials 592 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Completed

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

NCT00002445

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • AIDS Healthcare Foundation Los Angeles, California, United States
  • LAGLC Los Angeles, California, United States
  • USC School of Medicine / Norris Cancer Hosp Los Angeles, California, United States
  • Tower ID Med Associates Los Angeles, California, United States
View all 42 locations
View Trial Details
Completed

A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

NCT00002093

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • Univ of Arizona / Arizona Cancer Ctr Tucson, Arizona, United States
  • Kenneth Norris Jr Cancer Hosp Los Angeles, California, United States
  • Desert Hosp Comprehensive Cancer Ctr Palm Springs, California, United States
  • Saint Francis Mem Hosp San Francisco, California, United States
View all 13 locations
View Trial Details
Completed

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

NCT00002226

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • Norris Cancer Ctr / USC Los Angeles, California, United States
  • UCLA Care Ctr / Ctr for Hlth Sciences Los Angeles, California, United States
  • Saint Francis Mem Hosp / HIV Care Unit San Francisco, California, United States
  • New York Univ Med Ctr New York, United States
View Trial Details
Terminated

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

NCT05827614

Conditions
Anogenital Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Sarcoma Oncology Santa Monica, California, United States
  • HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
View all 16 locations
View Trial Details

Related conditions